For short-term storage prior to reconstitution, refrigeration at 2-8C is acceptable
doi: 10.1016/j.sxmr.2021.10.002 16 de RondeWSmitDL
Mechanism of Action Enhances glucose-dependent insulin secretion Suppresses glucagon release Delays gastric emptying Promotes satiety via central appetite regulation Pharmacokinetics Route: Subcutaneous (once weekly) Half-life: ~1 week Metabolism: Proteolytic degradation Excretion: Urine and feces Clinical Benefits HbA1c reduction of ~11.5% Significant weight loss (515%) Proven cardiovascular protection Minimal risk of hypoglycemia when used alone Adverse Effects Common: Nausea, vomiting, diarrhea Rare: Pancreatitis, gallbladder disease Contraindicated in medullary thyroid carcinoma / MEN-2 The Bigger Picture -The transition of semaglutide from a high-cost, premium therapy to an affordable mass drug represents a paradigm shift
23,24 30,99 Package size: 120 caps
These medications work by: Increasing insulin secretion Slowing down gastric emptying Reducing appetite and food intake Improving blood sugar control Common GLP-1 medication names include: Semaglutide (Ozempic, Wegovy) Liraglutide (Saxenda, Victoza) Dulaglutide (Trulicity) What Are GIP Receptor Agonists